AddLife AB Series B | Income Statement

Fiscal year is January-December. All values SEK Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
907
984
1,057
1,938
2,333
2,482
Cost of Goods Sold (COGS) incl. D&A
567
624
677
1,268
1,568
1,677
Gross Income
339
360
380
670
766
805
SG&A Expense
242
256
271
530
608
634
EBIT
97
104
109
140
158
165
Unusual Expense
-
-
-
-
2
1
Non Operating Income/Expense
-
2
3
8
10
1
Interest Expense
1
1
1
6
9
7
Pretax Income
98
102
105
142
158
158
Income Tax
23
24
25
30
37
29
Consolidated Net Income
74
78
80
112
120
129
Net Income
74
78
80
112
120
129
Net Income After Extraordinaries
74
78
80
112
120
129
Net Income Available to Common
74
78
80
112
120
129
EPS (Basic)
3.40
3.59
3.70
4.87
4.95
5.10
Basic Shares Outstanding
22
22
22
23
24
25
EPS (Diluted)
3.40
3.59
3.70
4.87
4.94
5.10
Diluted Shares Outstanding
22
22
22
23
24
25
EBITDA
122
129
131
199
246
264
Other Operating Expense
-
-
-
-
-
6
Non-Operating Interest Income
-
2
1
1
-
-
Minority Interest Expense
-
1
-
-
-
-

About AddLife AB

View Profile
Address
Birger Jarlsgatan 43
Stockholm AB 103 62
Sweden
Employees -
Website http://www.add.life
Updated 07/08/2019
AddLife AB engages in the marketing and sale of instruments, equipment, consumables and related services mainly to the healthcare sector in the Nordics. It operates through the Labtech and Medtech segments. The Labtech segment offers products and services in diagnostics, as well as biomedical research and laboratory equipment.